Showing 8291-8300 of 18597 results for "".
- Shifting Focus: Investigators Describe Changes to Pancreatic β Cell at Onset of Type 1 Diabeteshttps://reachmd.com/news/shifting-focus-investigators-describe-changes-to-pancreatic-cell-at-onset-of-type-1-diabetes/2457349/Therapeutic Targeting of Mechanistic Pathway Has The Potential to Slow Disease Progression In Mice and HumansBOSTON – About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its
- Weight Loss Intervention in People with Type 2 Diabetes Influences Cancer-Associated Proteinshttps://reachmd.com/news/weight-loss-intervention-in-people-with-type-2-diabetes-influences-cancer-associated-proteins/2456997/A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study, published in eBioMedicine, is the first to show that weight loss in people recently diagnosed with di
- Increased Body and Abdominal Fat in Teenagers Can Lead to ‘Vicious Cycle’ Ending in Type 2 Diabeteshttps://reachmd.com/news/increased-body-and-abdominal-fat-in-teenagers-can-lead-to-vicious-cycle-ending-in-type-2-diabetes/2456891/High fat mass in adolescence causes insulin resistance, which can lead to a “vicious cycle” of worsening insulin resistance and obesity by young adulthood and increased risk of type 2 diabetes. These findings come from a study conducted in collaboration between Univ
- Ultrasound Elastography Tracks Reversible Masseter Remodeling After BoNT-A Injectionshttps://reachmd.com/news/ultrasound-elastography-tracks-reversible-masseter-remodeling-after-bont-a-injections/2484690/Botulinum neurotoxin type A (BoNT-A) induces reversible changes in both masseter volume and elasticity, according to a new prospective study using ultrasound elastography (USE) to quantify structural adaptation post-injection. The findings, published ahead of print
- Orforglipron: A New Oral GLP-1 Receptor Agonist in Type 2 Diabetes Carehttps://reachmd.com/news/orforglipron-a-new-oral-glp-1-receptor-agonist-type-2-diabetes-care/2475779/As the management of type 2 diabetes evolves, orforglipron is emerging as an oral GLP-1 receptor agonist with promising potential for efficacy and convenience. For many clinicians, the challenge of treating type 2 diabetes lies in delivering robust glycemic control while respecting p
- New Clues Into Hypoglycemia Awareness: Protein Levels May Signal Brain Adaptations in Type 1 Diabeteshttps://reachmd.com/news/new-clues-into-hypoglycemia-awareness-protein-levels-may-signal-brain-adaptations-in-type-1-diabetes/2484004/A recent proteomics study has identified a potential biomarker linked to impaired awareness of hypoglycemia (IAH), a dangerous complication of type 1 diabetes that leaves patients unable to sense when their blood glucose drops
- Optimizing Glycemic Control in COPD Patients with Type 2 Diabetes: Evolving Strategies for Better Outcomeshttps://reachmd.com/news/optimizing-glycemic-control-in-copd-patients-with-type-2-diabetes-evolving-strategies-for-better-outcomes/2475530/Managing Type 2 Diabetes in patients with chronic obstructive pulmonary disease demands a seamless integration of endocrinological and pulmonary care, as elevated blood glucose levels have b
- Ozempic May Lower Dementia Risk in People With Type 2 Diabetes, Study Findshttps://reachmd.com/news/ozempic-may-lower-dementia-risk-in-people-with-type-2-diabetes-study-finds/2467565/Semaglutide, the main active ingredient in Ozempic, is linked to a lower risk of cognitive decline in a new study. The study only focused on patients with type 2 diabetes. Doctors say there may be something to this.
- Rising Challenge: Early-Onset Type 2 Diabetes in Young Adults and Emerging Technologieshttps://reachmd.com/news/rising-challenge-early-onset-type-2-diabetes-in-young-adults-and-emerging-technologies/2475646/Rates of early-onset type 2 diabetes among young adults have nearly doubled globally; in Sweden, recent studies observ
- Night Owls Are More Likely to Develop Type 2 Diabetes – And It’s Not Just Because of an Unhealthy Lifestyle, Dutch Study Findshttps://reachmd.com/news/night-owls-are-more-likely-to-develop-type-2-diabetes-and-its-not-just-because-of-an-unhealthy-lifestyle-dutch-study-finds/2468140/Night owls have a higher BMI, larger waists, more hidden body fat and are almost 50% more likely to develop type 2 diabetes (T2D) than those who go to bed earlier, new research to be presented at the Annual Meeting of the European Association fo